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Tat transloconWe have investigated the ﬁnal steps of complex iron–sulfur molybdoenzyme (CISM) maturation using
Escherichia coli DMSO reductase (DmsABC) as a model system. The catalytic subunit of this enzyme, DmsA,
contains an iron–sulfur cluster (FS0) and a molybdo-bis(pyranopterin guanine dinucleotide) cofactor
(Mo-bisPGD). We have identiﬁed a variant of DmsA (Cys59Ser) that renders enzyme maturation sensitive
to molybdenum cofactor availability. DmsA-Cys59 is a ligand to the FS0 [4Fe–4S] cluster. In the presence of
trace amounts of molybdate, the Cys59Ser variant assembles normally to the cytoplasmic membrane and
supports respiratory growth on DMSO, although the ground state of FS0 as determined by EPR is converted
from high-spin (S = 3/2) to low-spin (S = 1/2). In the presence of the molybdenum antagonist tungstate,
wild-type DmsABC lacks Mo-bisPGD, but is translocated via the Tat translocon and assembles on the periplasmic
side of the membrane as an apoenzyme. The Cys59Ser variant cannot overcome the dual insults of amino acid
substitution plus lack of Mo-bisPGD, leading to degradation of the DmsABC subunits. This indicates that the
cofactor can serve as a chemical chaperone to mitigate the destabilizing effects of alteration of the FS0 cluster.
These results provide insights into the role of the Mo–bisPGD–protein interaction in stabilizing the tertiary
structure of DmsA during enzyme maturation.
© 2013 Published by Elsevier B.V.1. Introduction
Members of the bacterial complex iron sulfur molybdoenzyme
(CISM) family play critical roles in global geochemical cycles and bac-
terial metabolic diversity, contributing to the ability of prokaryotes to
exploit the plethora of ecological niches on Earth [1,2]. Archetypal
members comprise a catalytic subunit containing a molybdo-
bis(pyranopterin guanine dinucleotide) cofactor (Mo-bisPGD) and a
single [4Fe–4S] cluster known as FS0, an electron-transfer subunit
that typically contains four [4Fe–4S] clusters, and a membrane–
anchor subunit that can contain zero or two b-type hemes. These
enzymes support metabolic diversity by coupling redox reactions
of soluble substrates at the Mo-bisPGD to the membrane-intrinsic
quinone pool via a ~70 Å to ~100 Å long multi-cofactor electron-
transfer relay and a quinone binding site located in the membrane–






, 474Medical Sciences Building,
7. Tel.: +1 780 492 2761; fax:
r).
sevier B.V.derived from the utility of the Mo-bisPGD in catalyzing redox reactions
ranging from the oxidation of formate to CO2 (Em,7 = −432 mV) to the
reduction of nitrate to nitrite (Em,7 = +420 mV) [6].While delineation
of theMo-bisPGD biosynthetic pathway is largely complete [7], the ﬁnal
steps of its insertion into the respective enzymes remain poorly under-
stood, and involve a system-speciﬁc chaperone referred to as a redox
enzyme maturation protein (REMP) [8].
Maturation of two Escherichia coli CISMenzymes has been studied in
detail: nitrate reductase A (NarGHI) and DMSO reductase (DmsABC)
[2,8–10]. Importantly, NarGHI is assembled to the inner surface of the
cytoplasmic membrane, whereas DmsABC is assembled to the outer
surface, with the DmsAB subunits being translocated across the mem-
brane by the Tat translocon [11,12]. In both cases, a REMP, NarJ or
DmsD, is required to facilitate both Mo–bisPGD insertion and correct
targeting of the enzyme to the cytoplasmic membrane. In the case of
NarGHI, NarJ appears to hold the apomolybdoenzyme in a cofactor-
binding competent conformation during the ﬁnal stages of maturation
[13], and appears to do this by interacting with two sites on the NarG
subunit: the approximately 50 amino acid pseudo-Tat leader and a sec-
ond as-yet unidentiﬁed site elsewhere on the subunit [14–16]. In the
case of DmsABC, a Tat-leader at the N-terminus of DmsA directs the
fully-folded cofactor-containing DmsAB catalytic dimer to the periplas-
mic compartment by binding DmsD and being directed to the Tat
translocon, where it associates with the membrane intrinsic DmsC
subunit to form an active heterotrimer. Support for a role of DmsD in co-
factor insertion comes from the observation that if the DmsA Tat leader
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ductase (TorA), DmsABC assembles to themembrane in its apomolybdo
form [17], indicating a role for the cognate REMP in both targeting and
cofactor insertion.
An aspect of CISM maturation that has received little attention is
the interplay between FS0 assembly and Mo-bisPGD insertion. In
the case of NarGHI, mutation of NarG-His50 to Ser results in assembly
of an enzyme lacking both FS0 and Mo-bisPGD [18]. Mutants of the
FS0-coordinating Cys motif in DmsA that eliminate its detection by
EPR also eliminate insertion of Mo-bisPGD [19]. These observations
indicate that correct assembly of FS0 is a prerequisite for Mo-bisPGD
insertion; speciﬁcally that correct folding of the FS0-binding domain
of the CISM catalytic subunit, known as Domain I [1], is a prerequisite
for cofactor insertion. In the absence of insertion-competent cofactor,
for example in cells grown in the presence of the molybdenum-
antagonist tungstate or in cells bearing a mutation in the cofactor
biosynthetic pathway, both enzymes are able to bypass the cofactor-
insertion step and assemble to the cytoplasmic membrane in their re-
spective apomolybdo forms [2,20–22]. These observations prompted
us to address the role of the FS0-pyranopterin interplay in the assembly
of DmsABC in a variant with an altered FS0 cluster that destabilizes
DmsA, DmsA-Cys59Ser. One intriguing aspect of this is that the esti-
mated ~30 contacts [23] between the Mo-bisPGD and the protein
may be able to play a role in stabilizing the structure of DmsA during
enzyme maturation. In this paper, we demonstrate that Mo-bisPGD
can act as a chemical chaperone [24] to stabilize a functional DmsA-
Cys59Ser variant.
2. Materials and methods
2.1. Bacterial strains and plasmids
The E. coli strains and plasmids used in this study are listed in
Table 1. E. coli strains HB101 and TOPP2 each have a wild-type chro-
mosomal copy of the dmsABC operon, resulting in accumulation of
both wild-type and variant DmsABC [25,26]. In E. coli DSS301, the
chromosomal copy of the dmsABC operon is replaced with a kanamy-
cin resistance cartridge [27]. Plasmid pDMS160 bears the wild-type
dmsABC operon behind an fnr-dependent promoter [25]. pDMS160-
C59S has a point mutation that changes Cys59 of DmsA to a Ser [26].
As a control, the same vector lacking the dmsABC operon (pBR322)
was used.
2.2. Growth of cells and preparation of membrane vesicles
Cells were grown anaerobically in 9 L or 19 L batch cultures at 37 °C
for 24 h (TOPP2 and DSS301) or 48 h (HB101) on a glycerol–fumarate
minimal medium [28]. The growth medium was supplemented with
either molybdate or tungstate (concentrations used are given in the in-
dividual table and ﬁgure legends). Where appropriate, ampicillin and
kanamycin were added to a ﬁnal concentration of 100 μg mL−1 andTable 1
Bacterial strains and plasmids.
Description
Strains
HB101 supE44 hsd20 (rB− mB−) recA13 ara-14 proA2 lacY1 galK2
rpsL20 xyl-5 mtl-1
DSS301 TG1, kanR ΔdmsABC
TOPP2 rifR F′ proAB, lacIqZΔM15 Tn10 (tetR)
F36 HB101, moeB
RK5209 ΔlacU169 araD139 rpsL gyrA non mod241::Mu cts
Plasmids
pDMS160 pBR322 AmpR (dmsABC)+
pDMS160C59S pBR322 AmpR (dmsACys59SerBC)+50 μg mL−1. Cells were harvested, and washed in 100 mM MOPS and
5 mM EDTA (pH7.0). Membranes were prepared by cell lysis using a
French pressure cell or an Avestinmicro-ﬂuidizer, followed by differen-
tial centrifugation as previously described [25,29]. Respiratory growth
on DMSO was evaluated using a Klett–Summerson spectrophotometer
and 160 mL side-armErlenmeyer ﬂasks as previously described [20,25].
2.3. Puriﬁcation of DmsABC
Membranes were detergent-solubilized with 1% n-dodecy-β-D-
maltoside and enzyme puriﬁcation was performed as previously
described [19].
2.4. Protein assays
Protein concentrations were determined by the Lowry method
[30], modiﬁed by the inclusion of 1% (wt/vol) sodium dodecyl sulfate
in the incubation mixture to solubilize membrane proteins [31].
2.5. Immunoblot analysis of DmsABC content in cell membranes
Proteins from membrane vesicles were separated on a 12% SDS-
PAGE gel and then blotted onto nitrocellulose. Antibodies to DmsA
and DmsB were used for Western blot analysis. DmsA and DmsB
were detected using the GE Healthcare chemiluminescence system
and goat anti-rabbit IgG horseradish peroxidase conjugate [32].
2.6. Preparation of ﬂuorescent pyranopterin derivatives
The presence of pyranopterin in membrane vesicles was assayed
by acid denaturation followed by I2 and KI oxidation to produce
an extract that contained the Form A ﬂuorescent derivative of
pyranopterin that will be referred herein to as a “Form A extract”
[21,33]. 20 mg of membrane protein was used as starting material.
Prior to recording ﬂuorescence spectra using a Perkin-Elmer LS-50B
luminescence spectrometer, small aliquots (200 μL) of the acid-
denatured iodine-oxidized extract were added to 3 mL of 1 M NH4OH
in a ﬂuorescence cuvette. Excitation spectra were recorded from 240–
420 nm (emission at 448 nm). Emission spectra were recorded from
410–520 nm (excitation at 397 nm).
2.7. Quantitation of quinol-binding to DmsABC
Fluorescence quench titrations were used to quantitate membrane-
bound DmsABC by measuring the concentration of 2-n-heptyl-4-
hydroxyquinoline-N-oxide (HOQNO) binding sites [19,34]. HOQNO is
a menaquinol analog that binds to the quinol-binding site of DmsC
with 1:1 stoichiometry and high afﬁnity (Kd ~ 7 nM). Quenching of
HOQNO ﬂuorescence was used to estimate the concentration of DmsC
and thus DmsABC in the membrane samples [35,36]. HOQNO ﬂuores-
cencewas recorded using a Perkin-Elmer LS-50B luminescence spectro-
photometer using an excitationwavelength of 341 nm and an emission
wavelength of 479 nm. Aliquots of 0.1 mM HOQNO were added to
membrane samples at a protein concentration of 1 mg mL−1. The con-
centration of DmsABC is equal to the concentration of HOQNO immedi-
ately preceding the rise in ﬂuorescence [37].
2.8. Enzyme activity assay
Enzyme activity was determined as the rate of trimethylamine-
N-oxide (TMAO)-dependent oxidation of dithionite-reduced benzyl
viologen (BV) as previously described [38]. The extinction coefﬁcient
for BV is 7.4 mM−1 cm−1.
Fig. 1. Electron-transfer relay architecture and predicted DmsA structure around FS0.
(A) Overall topology and electron-transfer relay of DmsABC in the cytoplasmic
membrane with the DmsAB catalytic dimer attached to the periplasmic side of DmsC.
The approximate position of the quinone binding site is indicated as a “Q” in the
panel, and blue cubes represent the ﬁve [4Fe-4S] clusters of DmsABC. (B) Structural
model of DmsA in the vicinity of FS0 was generated as previously described [19]. The
predicted position of the DmsA-Cys59 is shown. The distances shown are arbitrary.
PPT-P, proximal pyranopterin.
Fig. 2. Tungstate decreases enzyme maturation in a DmsA-Cys59Ser variant. Western
blot of membrane samples run on a 10% SDS-polyacrylamide gel with 45 μg (total
protein) of the following membrane samples: lane 1, E. coli DSS301/pDMS160 in the
presence of 5 μM sodium molybdate; lane 2, E. coli DSS301/pDMS160 in the presence
of 100 μM sodium tungstate; lane 3, E. coli DSS301/pDMS160C59S in the presence of
5 μM sodium molybdate; lane 4, E. coli DSS301/pDMS160C59S in the presence of
100 μM sodium tungstate; lane 5, E. coli DSS301/pBR322 in the presence of 5 μM
sodium molybdate; lane 6, E. coli DSS301/pBR322 in the presence of 100 μM sodium
molybdate; lane 7, puriﬁed DmsABC standard.
732 H. Tang et al. / Biochimica et Biophysica Acta 1827 (2013) 730–7372.9. Electron paramagnetic resonance (EPR) spectroscopy
Reduced samples were prepared by anaerobic incubation of
puriﬁed DmsABC or membrane samples with 5 mM (ﬁnal concentra-
tion) sodium dithionite for 5 min at room temperature. Oxidized
samples were prepared by mixing with air. Redox titrations were
carried out anaerobically at 25 °C under argon in the presence of redox
dyes as previously described [29,39,41]. The dyes added to a ﬁnal
concentration of 50 μM were quinhydrone, 2,6-dichloroindophenol,
1,2-naphthoquinone, toluylene blue, phenazine methosulfate,
thionine, duroquinone, methylene blue, resoruﬁn, indigotrisulfonate,
indigodisulfonate, anthraquinone-2-sulfonic acid, phenosafranine, ben-
zyl viologen, and methyl viologen. All samples were prepared in 3 mm
internal diameter quartz EPR tubes, and were rapidly frozen in liquid
nitrogen-chilled ethanol and stored under liquid nitrogen until use.
EPR spectra were recorded using a Bruker ELEXSYS E500 spectrometer
equipped with a Bruker SHQE cavity and an Oxford Instruments
ESR-900 ﬂowing helium cryostat, or with a Bruker ESP300E equipped
with a TE102 cavity andwith either a ESR-900 cryostat or a Bruker liquid
nitrogen evaporating cryostatwas used (Bruker ER4111VT). Instrument
conditions and temperatures used were are described in the ﬁgure leg-
ends. Microwave power saturation data were analyzed as previously
described [39,41].
3. Results
3.1. DmsA-Cys59 coordinates the FS0 cluster of DmsA
The electron-transfer relay connecting the menaquinol binding
site within the DmsC subunit to the Mo-bisPGD cofactor of DmsA
comprises four [4Fe–4S] clusters located in the DmsB subunit and
the FS0 [4Fe–4S] cluster of DmsA that is close to the proximal
pyranopterin of the cofactor [1,19] (Fig. 1A). Fig. 1B shows the
predicted protein structure surrounding the FS0 cluster with DmsA-
Cys59 providing one of its four sulfur ligands [19]. The work
presented herein addresses the effect of a DmsA-Cys59Ser variant in
rendering assembly of the DmsABC complex (Fig. 1B) sensitive to
the availability of the Mo-bisPGD cofactor.
3.2. Assembly of the DmsA-Cys59Ser variant is impaired by growth in the
presence of tungstate
Membrane fractions from E. coli DSS301 cells (ΔdmsABC) express-
ing either wild-type enzyme or the DmsA-Cys59Ser variant in the
presence of either molybdate or tungstate were subjected to immu-
noblot analysis (Fig. 2). While growth in the presence of the molybde-
num antagonist tungstate has no demonstrable effect on the assembly
of wild-type enzyme, it clearly diminishes assembly of the DmsA-
Cys59Ser variant. Given the large number of contacts between the
Mo-bisPGD and the protein [23], this observation is consistent with
the Mo-bisPGD acting as a chemical chaperone [24] during maturation
of the DmsA-Cys59Ser variant.
3.3. The DmsA-Cys59Ser variant supports respiratory growth on DMSO
Fig. 3A conﬁrms that, as reported previously, the DmsA-Cys59Ser
variant supports respiratory growth on DMSO in DSS301, a ΔdmsABC
mutant [26]. As expected, this growth is inhibited by the molybde-
num antagonist tungstate. Similar behavior is exhibited when the
wild-type HB101 strain is used (Fig. 3B), with the only signiﬁcant dif-
ference being the slower overall growth rate exhibited by this strain.
As E. coli HB101 expresses higher levels of DmsABC in comparison
with DSS301, membrane preparations for ﬂuorescence and EPR
studies were prepared from HB101 cells grown anaerobically on a
glycerol–fumarate minimal medium [25,28].
Fig. 3. Effect of tungstate on respiratory growth on DMSO. (A) Growth of E. coli DSS301.
(B) Growth of E. coliHB101. Squares— E. coliHB101/pDMS160 in the absence of tungstate.
Circles — E. coli HB101/pDMS160C59S in the absence of tungstate. Triangles — E. coli
HB101/pDMS160 in the presence of 10 mM tungstate. Diamonds — E. coli HB101/
pDMS160C59S in the presence of 10 mM tungstate. Cell growth was measured with a
Klett–Summerson spectrophotometer equipped with a number 66 ﬁlter.
Fig. 4. Loss of cofactor inhibits assembly of the DmsA-Cys59Ser variant. (A) Fluorescence
spectra of Form A extracts of membranes from cells grown in the presence of molybdate
and tungstate. (i) Spectra of membranes from E. coli HB101/pDMS160 cells expressing
wild-type DmsABC grown in the presence of 5 μMmolybdate; (ii) spectra of membranes
from E. coliHB101/pDMS160C59S cells in the presence of 5 μMmolybdate; (iii) spectra of
membranes from E. coli HB101/pDMS160C59S cells grown in the presence of 15 mM
tungstate; and (iv) difference spectra of (ii) minus (iii). 10 mg of membrane protein
was used as starting material. Spectra were recorded under the following conditions:
excitation spectra (left of panel A), scanned from 240–420 nm with an emission wave-
length of 442 nm; emission spectra (right of panel A), scanned from 410–520 nm with
an excitation wavelength of 395 nm. (B) Quantitation by ﬂuorescence quench titration
of quinol binding sites in membranes containing DmsABC or DmsA-Cys59Ser variant
enzyme. Circles — membranes containing wild-type enzyme; triangles — membranes
from cells expressing the DmsA-Cys59Ser variant in the presence of 5 μM molybdate;
squares —membranes from cells expressing the DmsA-Cys59Ser variant in the presence
of 15 mM tungstate. Enzyme concentrations were estimated from the X-intercepts of
the plots to be 0.54, 0.48, and 0.17 nmol (mg membrane protein)−1 for the wild-type,
DmsA-Cys59Ser variant (molybdate), and the DmsA-Cys59Ser variant (tungstate) mem-
branes, respectively. Titrations were carried out at a protein concentration of 1 mg mL−1.
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DmsA-Cys59Ser variant
The pyranopterin cofactor cannot be assayed directly and an oxi-
dized ﬂuorescent derivative Form A is used as a measure of cofactor
insertion. Fig. 4A shows the effect of tungstate on the relative
amounts of Form A pyranopterin derivative in membrane fractions
derived from the HB101 strain. As expected (Fig. 4Ai, Aii), a signiﬁ-
cant amount of cofactor is detected in membranes prepared from
cells grown in the presence of molybdate [20,21]. The level of Form
A derivative prepared from the DmsA-Cys59Ser variant is comparable
to that obtained from wild-type DmsABC (cf. Fig. 4Ai and Aii).
As expected, growth in the presence of tungstate decreases the
amount of cofactor released from membranes containing wild-type
or DmsA-Cys59Ser enzyme (Fig. 4Aiii). We have previously demon-
strated that in both DmsABC and NarGHI, growth in the presence of
tungstate has little or no effect on the total amount of enzyme assem-
bled to the cytoplasmic membrane [20,21]. Overall, analyses of Form
A extracts frommembranes are consistent with the immunoblot anal-
ysis presented in Fig. 2.
It is important to correlate cofactor detection by assaying Form A
extracts with the overall assembly of the enzyme. Fluorescence
quench titrations using the chromophore HOQNO allow the concen-
tration of DmsABC-associated quinol binding sites to be measured
in membrane samples [34,37]. Fig. 4B shows titrations performed
with HB101 membranes containing wild-type, DmsA-Cys59Ser variant(molybdate) andDmsA-Cys59Ser variant (tungstate) enzymes, yielding
HOQNO binding site concentrations of 0.54, 0.48, and 0.17 nmol (mg
membrane protein)−1, respectively. Growth in the presence of
tungstate has no effect on the amount of HOQNO binding sites detected
in membranes containing DmsABC accumulated to the cytoplasmic
membrane as assayed by immunoblot (Fig. 2) and ﬂuorescence quench
titration (data not shown). Essentially similar results were obtained
using the alternative wild-type strain E. coli TOPP2 (data not shown).
These results demonstrate that in the DmsA-Cys59Ser variant there is
a correlation between a decreased level of DmsA and DmsB subunits
detected by immunoblot (Fig. 2)with a decreased level of FormA deriv-
ative released from membrane samples (Fig. 4A) and a decreased
734 H. Tang et al. / Biochimica et Biophysica Acta 1827 (2013) 730–737concentration of detectable HOQNO binding sites. Critically, this sug-
gests a coordination of the maturation of all three subunits of the
holoenzyme.3.5. EPR characterization of the DmsA-Cys59Ser variant
Fig. 5 shows EPR spectra recorded at 12 K of dithionite-reduced
membranes containing wild-type DmsABC and the DmsA-Cys59Ser
variant expressed in the presence and absence of tungstate. As
expected, the spectrum of membranes containing wild-type DmsABC
(Fig. 5a) resembles those previously published [29,38]. It arises from
the paramagnetic [4Fe–4S] clusters located in the DmsB subunit and
has well-deﬁned peaks at around g = 2.05, 2.02, and 1.99; and well
deﬁned troughs at g = 1.92 and 1.88 [29,38]. Because the mem-
branes were derived from cells that were grown anaerobically on
fumarate, there is a minor contribution to the spectrum from the
[Fe–S] clusters of fumarate reductase [25,26,29]. Speciﬁcally, fuma-
rate reductase contributes to the peak at g = 2.02 and to the trough
at g = 1.92. Spectra of membranes containing the DmsA-Cys59Ser
variant (Fig. 5b) resemble those of membranes containing the wild-
type enzyme, but have a more pronounced peak at g = 2.05 (indicated
by the position of the arrows in Fig. 5). Spectra of membranes
containing the DmsA-Cys59Ser variant obtained from cells grown in
the presence of tungstate are greatly diminished in intensity and more
closely resemble those observed for membranes containing fumarate
reductase (Fig. 5c) [34]. When the spectrum of membranes grown in
the presence of tungstate is subtracted from the spectrum of mem-
branes grown in the presence of molybdate, the result resembles that
of puriﬁed enzyme [38] with the caveat that it has a more pronounced
peak at g = 2.05 (Fig. 5(c), see below).Fig. 5. Effect of tungstate on assembly of the DmsA-Cys59Ser variant determined by EPR
spectroscopy of its clusters. All spectra are of dithionite (5 mM) reduced samples prepared
as described in the Materials and methods section. (a) Spectrum of HB101/pDMS160
membranes from cells grown on molybdate-supplemented medium. (b) Spectrum of
HB101/pDMS160C59Smembranes from cells grown onmolybdate-supplementedmedium.
(c) Spectrum of HB101/pDMS160C59S membranes grown on tungstate-supplemented
medium(15 mM). (d)Difference spectrumof (b)minus0.8× (c). EPR spectrawere recorded
under the following instrument conditions: temperature, 12 K; microwave power, 20 mW;
microwave frequency, 9.47 GHz; modulation amplitude, 10 Gpp at 100 KHz. Spectra
were normalized to a protein concentration of 30 mg mL−1. Vertical arrows indicate the in-
creased intensity of the g = 2.05 peak in spectra of samples containing the DmsA-Cys59Ser
variant.3.6. Characterization of the FS0 cluster of the DmsA-Cys59Ser variant
Because DmsA-Cys59 is a ligand to the FS0 cluster and this cluster
is close to the Mo-bisPGD (Fig. 1B), it is important to evaluate any
effects of a Cys59Ser substitution on the electrochemistry of both
the cluster and the Mo center. Fig. 6A shows a comparison of redox-
poised EPR spectra recorded at 75 K, demonstrating that the Mo(V)Fig. 6. EPR characterization of Mo-bisPGD in the DmsA-Cys59Ser variant. (A). Mo(V)
EPR spectra of membranes containing wild-type (i) and DmsA-Cys59Ser variant
enzyme (ii). Samples were redox-poised as described in the Materials and methods
section at −91 mV (i) and −98 mV (ii). Spectra were recorded with the following
EPR parameters: temperature, 75 K, modulation amplitude, 3.8 Gpp at 100 KHz;
microwave power, 2 mW. (B). Redox titration of the g = 1.98 peak-trough of the
wild-type and DmsA-Cys59Ser variant Mo(V) signals. Squares — wild-type (Mo(V/VI)
Em,7 = −5 mV, Mo(IV/V) Em,7 = −140 mV). Triangles — DmsA-Cys59Ser variant
(Mo(V/VI) Em,7 = −10 mV, Mo(IV/V) Em,7 = −128 mV). Data were obtained from
EPR spectra recorded as described for (A). (C) Microwave power saturation curves
for the g = 1.98 peak-trough of the DmsA-Cys59Ser variant Mo(V) spectrum of
redox-poised samples. Squares — Eh = −29 mV (P1/2 = 1.4 mW, b = 1.6). Triangles —
Eh = −138 mV (P1/2 = 1.5 mW, b = 1.6, 82%). Diamonds — Eh = −179 mV (P1/2=
1.1 mW, b = 1.6, 70%). Percentages indicate the estimated amount of saturable versus
non-saturable Mo(V). Where appropriate, a non-saturable component with nominal P1/2
of 1000 mWwas included in the ﬁts. EPR spectra were recorded as described for A, except
that the temperature was 30 K and the modulation amplitude was 6Gpp.
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that of the wild-type. Fig. 6B illustrates redox titrations of Mo for the
two enzymes. The wild-type enzyme has reduction potentials (Em,7
values) of approximately −5 mV (Mo(VI/V)) and −140 mV (Mo(V/
IV)), whereas the DmsA-Cys59Ser variant has reduction potentials
of −10 mV (Mo(VI/V)) and −128 mV (Mo(V/IV)). Thus, there is
modest 12 mV increase in the Mo(V/IV) reduction potential in the
DmsA-Cys59Ser variant compared to the wild-type. A ﬁnal issue
that can be addressed by studying the Mo(V) EPR spectrum is the
paramagnetic interaction between it and the reduced form of the
FS0 cluster [39]. Fig. 6C shows the change in spin relaxation of the
Mo(V) center that occurs as the ambient potential is decreased from
−29 mV to −179 mV [1,39]. As the potential is decreased, the
proportion of rapidly-relaxing Mo(V) signal increases, and in theFig. 7. EPR spectra of the puriﬁed DmsA-Cys59Ser variant. (A) EPR spectra recorded in
the g = 2.0 region showing oxidized (i) and dithionite-reduced (ii) wild-type enzyme;
and oxidized (iii) and reduced (iv) DmsA-Cys59Ser variant enzymes. (B) EPR spectra in
the low ﬁeld region showing the spectrum of reduced FS0 with a high-spin ground
state (I) and the lack of a similar spectrum exhibited by the puriﬁed DmsA-Cys59Ser
variant.wild-type enzyme, this phenomenon titrates with an apparent reduc-
tion potential of approximately −140 mV [39]. In the case of the
DmsA-Cys59Ser variant, an estimated 70% of the observable Mo(V)
is slowly-relaxing and thus not interacting with reduced FS0 at a
potential of −179 mV, indicating that the reduction potential of FS0
is signiﬁcantly lower than this value. It was not possible to explore
potentials lower than approximately −179 mV using this method,
as the intrinsic intensity of the Mo(V) spectrum becomes negligible
at lower potentials (Fig. 6B). Unfortunately, FS0 has proven recalci-
trant to efforts to directly measure the reduction potential of its
high-spin EPR spectrum [19] (see below).
To further investigate the line shape change observed in the low
temperature (12 K) EPR spectrum of the reduced DmsA-Cys59Ser
variant, we puriﬁed it from E. coli TOPP2 membranes [19]. Fig. 7
shows representative EPR spectra recorded at 9 K at around g = 2.0
(Fig. 7A) and at around g = 5.0 (Fig. 7B). Reduced spectra at around
g = 2.0 conﬁrm the difference between the wild-type and DmsA-
Cys59Ser variant observed in HB101 membranes in Fig. 5, with a
more pronounced shoulder observed at g = 2.05. Spectra of air oxi-
dized samples (Fig. 7A(i) and A(iii)) indicate that a fraction of FS0 is
converted to a [3Fe–4S] cluster in the DmsA-Cys59Ser variant (spec-
tral features comprising a peak at ~g = 2.02 with a peak-trough
immediately upﬁeld). Inspection of the spectra of reduced puriﬁed
samples at around g = 5 reveals that the increased intensity of the
g = 2.05 shoulder is correlated with the almost complete elimination
of a g = 5.07 signal corresponding to a form of the FS0 cluster with a
high-spin S = 3/2 ground state [19]. Based on these observations, it is
likely that the DmsA-Cys59Ser substitution changes the ground state
of the reduced FS0 from S = 3/2 to S = 1/2.
3.7. Effect of the DmsA-Cys59Ser variant on enzyme activity
In agreement with our previous work [26], the DmsA-Cys59Ser
variant is able to support respiratory growth on DMSO (Fig. 3). In
order to correlate the observed growth with enzyme activities, we
measured normalized enzyme activities corrected for enzyme con-
centration in E. coli TOPP2 membranes determined by ﬂuorescence
quench titration. The turnover number of wild-type and DmsA-
Cys59 variant enzymes from cells grown in the presence of 5 μMmo-
lybdate was 3240 s−1 and 3238 s−1, respectively, indicating that
these enzymes were both equally effective at reducing substrate
and consistent with their ability to support respiratory growth on
DMSO. Increasing concentrations of molybdate (up to 10 mM) had
no effect on the observed turnover rates. Finally, tungstate eliminated
measurable enzyme activity, consistent with it being an effective mo-
lybdenum antagonist.
4. Discussion
The results presented herein provide new insights into the inter-
play between the FS0 cluster and the Mo-bisPGD cofactor during mat-
uration of CISM catalytic subunits. We previously demonstrated in
both DmsABC and NarGHI that FS0 assembly into the respective
apomolybdoenzymes is a prerequisite for Mo-bisPGD insertion
[18,19]. In the present work, we show that in a DmsA-Cys59Ser vari-
ant, assembly of the entire complex is dependent on the availability of
Mo-bisPGD. This can be understood in the context of hydrogen bond
formation between the amino acids of DmsA and the cofactor: there
are approximately 30 predicted hydrogen-bonding contacts [23],
each of which is likely to stabilize the structure by between 5.7 to
27 kJ mol−1 [42,43]. In the wild-type enzyme, absence of cofactor
appears to have essentially no effect on the amount of protein assem-
bled to the membrane, presumably due to the large size and inherent
stability of DmsA (85.8 kDa; 768 amino acids) within the complex. In
the present study, we demonstrate that a combination of a critical
point mutation in DmsA and lack of cofactor results in signiﬁcant
736 H. Tang et al. / Biochimica et Biophysica Acta 1827 (2013) 730–737degradation of the entire DmsA-Cys59Ser variant complex: decreased
levels of DmsA and DmsB are observed in immunoblots; and negligi-
ble amounts of DmsC are detected by ﬂuorescent quench titration.
That all three subunits are affected by the DmsA-Cys59Ser substitu-
tion is also supported by the absence of the previously-observed
lethality effects of DmsC expression in the absence of DmsAB [44,45]:
when expressed by itself it uncouples the cytoplasmic membrane and
severely inhibits growth on minimal growth media including the
glycerol-fumarate medium used herein for protein expression. This is
consistent with misfolding of DmsA causing degradation of all three
subunits.
In agreement with our earlier observations on the assembly of both
DmsABC and NarGHI [20,21], the effect of tungstate on the relative
amounts ofwild-type enzyme assembled to the cytoplasmicmembrane
indicates that apomolybdo-enzymes can bypass Mo-bisPGD insertion
during maturation. In the case of DmsABC, this results in accumulation
of inactive membrane-bound enzyme on the periplasmic side of
the membrane [20], consistent with normal translocation of the
apomolybdo-DmsAB dimer across the cytoplasmic membrane by the
Tat translocon, followed by its association with DmsC. This parallels
what is observed with NarGHI [40], but with the important difference
that the NarGH catalytic dimer is assembled to the inside of the cyto-
plasmic membrane. Our observations have important implications for
the proposed “proofreading” function of the NarJ/DmsD chaperones
in that they do not appear to be able to discriminate between
apomolybdo- and molydo- forms of the enzyme. In the case of NarGHI,
comparison of the structure of the apomolybdo- and molybdo- forms
reveals no signiﬁcant changes in externally-apparent protein structure
that the cognate chaperone could use to distinguish between the two
enzyme forms [22].
We examined the properties of DmsA-Cys59Ser variant in the
presence of molybdate and found the enzyme had wild-type
cofactor occupancy, wild-type catalytic activity and it could support
anaerobic growth on DMSO. The EPR spectra and redox properties
of the Mo and the [Fe–S] clusters in DmsB resembled those of the
wild-type. The only observed difference was that the high-spin signal
from FS0 appears to be converted to a low-spin signal and only a
small fraction was converted from a [4Fe–4S] cluster to a [3Fe–4S]
cluster. Taken together these results indicate that a Ser side chain ox-
ygen is able to function as a ligand to FS0 and that the altered cluster
is still able to support catalytically-competent rates of electron trans-
fer during enzyme turnover. As is the case with the wild-type en-
zyme, we were unable to directly determine the reduction potential
of FS0 in the DmsA-Cys59Ser variant, but analysis of the
potential-dependence of the spin-relaxation of the Mo(V) EPR spec-
trum suggests that it is lower than −179 mV and signiﬁcantly
lower than that observed by similar measurements in the wild-type
enzyme (Em = −140 mV [39]). Broadly similar decreases in reduc-
tion potentials of the [4Fe–4S] cluster of E. coli fumarate reductase
are observed when coordinating Cys residues are replaced with Ser
residues [46].
Overall, our results provide new insights into the maturation of
CISM enzymes and the interaction between FS0 and Mo-bisPGD and
demonstrates that the latter can function as a chemical chaperone
during enzyme maturation.
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